Prostate Cancer - Results from #19040

Prostate cancer in 2014 - 2015: Advances and ongoing challenges in therapeutics, biomarkers, and precision medicine March 9, 2015

#GU15 - Novel imaging modalities boost detection of early metastatic disease in prostate cancer - Session Highlights March 9, 2015

Final report of the Intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer - Abstract March 7, 2015

Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results - Abstract March 7, 2015

Technological aspects of delivering cryotherapy for prostate cancer - Abstract March 6, 2015

Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS) - Abstract March 6, 2015

Is further screening of men with baseline PSA less than 1 ng ml-1 worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau) - Abstract March 6, 2015

Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases receiving antiandrogen therapy - Abstract March 6, 2015

Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy? - Abstract March 6, 2015

Systematic diagnosis of prostate cancer using an optical biopsy needle adjunct with fluorescence spectroscopy - Abstract March 6, 2015

Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database - Abstract March 6, 2015

Conditional probability of reclassification within an active surveillance program for prostate cancer - Abstract March 6, 2015

Ipilimumab in the treatment of prostate cancer - Abstract March 6, 2015

Sipuleucel-T in the treatment of prostate cancer: An evidence-based review of its place in therapy - Abstract March 6, 2015

Metastatic castration-resistant prostate cancer: Time for innovation - Abstract March 6, 2015

Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study - Abstract March 6, 2015

Intermittent chemotherapy as a platform for testing novel agents in patients with metastatic castration-resistant prostate cancer: - Abstract March 6, 2015

Peripheral photon and neutron doses from prostate cancer external beam irradiation - Abstract March 6, 2015

Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: Proof of principle and initial clinical experience with extraprostatic extension - Abstract March 5, 2015

Follow-up modalities in focal therapy for prostate cancer: Results from a Delphi consensus project - Abstract March 5, 2015

Page 953 of 1458